Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.
作者信息
Tan E M
机构信息
The Scripps Research Institute, MEM131, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.
出版信息
J Clin Invest. 2001 Nov;108(10):1411-5. doi: 10.1172/JCI14451.
Abstract
摘要
相似文献
1
Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.自身抗体作为识别肿瘤发生中异常细胞机制的报告分子。
J Clin Invest. 2001 Nov;108(10):1411-5. doi: 10.1172/JCI14451.
2
Antibodies as oncogenes: a hypothesis.
Med Hypotheses. 2006;67(3):471-3. doi: 10.1016/j.mehy.2006.03.006. Epub 2006 Apr 24.
3
[p53 mutations and their role in tumorigenesis].[p53突变及其在肿瘤发生中的作用]
Tanpakushitsu Kakusan Koso. 1997 Jul;42(10 Suppl):1567-75.
4
Immunological aspects of the autonomous behaviour of tumours.
Biomed Sci. 1990;1(6):565-70.
5
The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.致癌 RNA 结合蛋白 Musashi1 受肿瘤抑制 miRNA 的调控。
RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.
6
[Pdcd4 tumor suppressor: properties, functions, and their application to oncology].[程序性细胞死亡蛋白4肿瘤抑制因子：特性、功能及其在肿瘤学中的应用]
Mol Gen Mikrobiol Virusol. 2010(2):3-11.
7
p53 mutation heterogeneity in cancer.癌症中的p53突变异质性
Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. doi: 10.1016/j.bbrc.2005.03.190.
8
The p53 tumour suppressor gene.p53肿瘤抑制基因。
Nature. 1991 Jun 6;351(6326):453-6. doi: 10.1038/351453a0.
9
Methylation, mutation and cancer.甲基化、突变与癌症。
Bioessays. 1992 Jan;14(1):33-6. doi: 10.1002/bies.950140107.
10
Oncogenes and tumor suppressor genes as paradigms in oncogenesis.作为肿瘤发生范例的癌基因和肿瘤抑制基因。
J BUON. 2007 Sep;12 Suppl 1:S9-12.
引用本文的文献
1
The diagnostic efficacy of seven autoantibodies in early detection of ground-glass nodular lung adenocarcinoma.七种自身抗体在磨玻璃结节型肺腺癌早期检测中的诊断效能
Front Oncol. 2024 Nov 26;14:1499140. doi: 10.3389/fonc.2024.1499140. eCollection 2024.
2
Development and validation of a TAAbs and TAAs based non-invasive model for diagnosing lung cancer.基于肿瘤相关自身抗体（TAAbs）和肿瘤相关抗原（TAAs）的肺癌诊断非侵入性模型的开发与验证
Heliyon. 2024 Jun 29;10(13):e33888. doi: 10.1016/j.heliyon.2024.e33888. eCollection 2024 Jul 15.
3
Eng Meng Tan.陈英孟
Ann Rheum Dis. 2024 Sep 30;83(10):1256-1259. doi: 10.1136/ard-2024-226025.
4
High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia.骨髓增生异常综合征和急性髓系白血病患者中ENO1的高表达及循环抗ENO1自身抗体的低水平
Cancers (Basel). 2024 Feb 22;16(5):884. doi: 10.3390/cancers16050884.
5
Unraveling the complex interplay between anti-tumor immune response and autoimmunity mediated by B cells and autoantibodies in the era of anti-checkpoint monoclonal antibody therapies.在抗检查点单克隆抗体疗法时代，揭示B细胞和自身抗体介导的抗肿瘤免疫反应与自身免疫之间的复杂相互作用。
Front Immunol. 2024 Jan 22;15:1343020. doi: 10.3389/fimmu.2024.1343020. eCollection 2024.
6
Immunoseroproteomic profiling in autoantibody to ENO1 as potential biomarker in immunodiagnosis of osteosarcoma by serological proteome analysis (SERPA) approach.通过血清蛋白质组分析（SERPA）方法，对骨肉瘤免疫诊断中作为潜在生物标志物的抗烯醇化酶1自身抗体进行免疫血清蛋白质组分析。
Oncoimmunology. 2021 Sep 24;10(1):1966969. doi: 10.1080/2162402X.2021.1966969. eCollection 2021.
7
Identification of novel tumor-associated antigens and evaluation of a panel of autoantibodies in detecting oral cancer.鉴定新型肿瘤相关抗原并评估一组自身抗体在检测口腔癌中的应用。
BMC Cancer. 2023 Aug 28;23(1):802. doi: 10.1186/s12885-023-11247-w.
8
From Basic Science to Clinical Practice: The Role of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A)/p90 in Cancer.从基础科学到临床实践：蛋白磷酸酶2A癌性抑制剂（CIP2A）/p90在癌症中的作用
Front Genet. 2023 Feb 24;14:1110656. doi: 10.3389/fgene.2023.1110656. eCollection 2023.
9
Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab.评估接受环磷酰胺和帕博利珠单抗治疗的转移性三阴性乳腺癌患者的肿瘤抗原特异性抗体反应。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-005848.
10
Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs.液体活检在肺癌中的应用：筛查项目的最新进展和展望。
Int J Mol Sci. 2023 Jan 28;24(3):2505. doi: 10.3390/ijms24032505.
本文引用的文献
1
Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.乳糜泻发展过程中基因与环境的相互作用：健康生活的展望
J Clin Invest. 2001 Nov;108(9):1261-6. doi: 10.1172/JCI14344.
2
Thyroid autoimmunity.甲状腺自身免疫
J Clin Invest. 2001 Nov;108(9):1253-9. doi: 10.1172/JCI14321.
3
Autoimmune type 1 diabetes: resolved and unresolved issues.自身免疫性1型糖尿病：已解决和未解决的问题。
J Clin Invest. 2001 Nov;108(9):1247-52. doi: 10.1172/JCI14257.
4
Transcription activating property of autoantigen SG2NA and modulating effect of WD-40 repeats.自身抗原SG2NA的转录激活特性及WD-40重复序列的调节作用。
Exp Cell Res. 2001 Oct 1;269(2):312-21. doi: 10.1006/excr.2001.5320.
5
Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis.胎儿RNA结合蛋白p62在肝癌和肝硬化中的异常表达。
Am J Pathol. 2001 Sep;159(3):945-53. doi: 10.1016/S0002-9440(10)61770-1.
6
De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.从慢性肝病转变为肝细胞癌过程中对癌症相关自身抗原的从头体液免疫反应。
Clin Exp Immunol. 2001 Jul;125(1):3-9. doi: 10.1046/j.1365-2249.2001.01585.x.
7
Surfing the p53 network.探索p53网络
Nature. 2000 Nov 16;408(6810):307-10. doi: 10.1038/35042675.
8
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass.针对p53的自身免疫可预测卵巢肿块患者发生侵袭性癌症且生存预后不良。
Br J Cancer. 2000 Nov;83(10):1338-43. doi: 10.1054/bjoc.2000.1446.
9
What is missing in immunology to understand immunity?在免疫学中，要理解免疫还缺少什么？
Nat Immunol. 2000 Sep;1(3):181-5. doi: 10.1038/79712.
10
Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein.在人类乳腺癌中一种编码c-myc信使核糖核酸结合蛋白的基因的扩增。
Cancer Res. 2000 Jun 1;60(11):2756-9.
Zotero 插件